Bremus C, Herrmann U, Bringer-Meyer S, Sahm H. The use of microorganisms in l-ascorbic acid production.
J Biotechnol 2006;
124:196-205. [PMID:
16516325 DOI:
10.1016/j.jbiotec.2006.01.010]
[Citation(s) in RCA: 86] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2005] [Revised: 11/19/2005] [Accepted: 01/04/2006] [Indexed: 11/24/2022]
Abstract
L-Ascorbic acid has been industrially produced for around 70 years. Over the past two decades, several innovative bioconversion systems have been proposed in order to simplify the long time market-dominating Reichstein method, a largely chemical synthesis by which still a considerable part of L-ascorbic acid is produced. Here, we describe the current state of biotechnological alternatives using bacteria, yeasts, and microalgae. We also discuss the potential for direct production of l-ascorbic acid exploiting novel bacterial pathways. The advantages of these novel approaches competing with current chemical and biotechnological processes are outlined.
Collapse